Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease-Reference-Cited by-同舟云学术

Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease

Published:2010-09 Issue:7311 Volume:467 Page:95-98
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

He Gen,Luo Wenjie,Li Peng,Remmers Christine,Netzer William J.,Hendrick Joseph,Bettayeb Karima,Flajolet Marc,Gorelick Fred,Wennogle Lawrence P.,Greengard Paul

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09325.pdf

Reference26 articles.

1. Selkoe, D. J. Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766 (2001)

2. Steiner, H., Fluhrer, R. & Haass, C. Intramembrane proteolysis by gamma-secretase. J. Biol. Chem. 283, 29627–29631 (2008)

3. Lathia, J. D., Mattson, M. P. & Cheng, A. Notch: from neural development to neurological disorders. J. Neurochem. 107, 1471–1481 (2008)

4. Wong, G. T. et al. Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 279, 12876–12882 (2004)

5. Netzer, W. J. et al. Gleevec inhibits beta-amyloid production but not Notch cleavage. Proc. Natl Acad. Sci. USA 100, 12444–12449 (2003)

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease;Neuropharmacology;2024-11

2. Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases;Molecular Neurobiology;2024-04-19

3. Lung endothelium, tau, and amyloids in health and disease;Physiological Reviews;2024-04-01

4. Astrocytic functions and lipid metabolism: Correlations and therapeutic targets in Alzheimer's disease and glioblastoma;Clinical and Translational Discovery;2024-04

5. Navigating the Landscape of Alzheimer's Disease: From Epidemiology to Drug Re-purposing;Advances in Pharmacology and Pharmacy;2024-04